全文获取类型
收费全文 | 1677篇 |
免费 | 120篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 78篇 |
妇产科学 | 23篇 |
基础医学 | 282篇 |
口腔科学 | 66篇 |
临床医学 | 172篇 |
内科学 | 326篇 |
皮肤病学 | 62篇 |
神经病学 | 87篇 |
特种医学 | 267篇 |
外科学 | 114篇 |
综合类 | 19篇 |
预防医学 | 95篇 |
眼科学 | 18篇 |
药学 | 74篇 |
肿瘤学 | 140篇 |
出版年
2023年 | 4篇 |
2022年 | 6篇 |
2021年 | 16篇 |
2020年 | 6篇 |
2019年 | 18篇 |
2018年 | 36篇 |
2017年 | 13篇 |
2016年 | 18篇 |
2015年 | 26篇 |
2014年 | 37篇 |
2013年 | 46篇 |
2012年 | 61篇 |
2011年 | 52篇 |
2010年 | 51篇 |
2009年 | 33篇 |
2008年 | 57篇 |
2007年 | 65篇 |
2006年 | 67篇 |
2005年 | 51篇 |
2004年 | 38篇 |
2003年 | 61篇 |
2002年 | 43篇 |
2001年 | 48篇 |
2000年 | 46篇 |
1999年 | 39篇 |
1998年 | 74篇 |
1997年 | 83篇 |
1996年 | 92篇 |
1995年 | 60篇 |
1994年 | 47篇 |
1993年 | 53篇 |
1992年 | 36篇 |
1991年 | 25篇 |
1990年 | 31篇 |
1989年 | 49篇 |
1988年 | 51篇 |
1987年 | 37篇 |
1986年 | 42篇 |
1985年 | 41篇 |
1984年 | 17篇 |
1983年 | 21篇 |
1982年 | 17篇 |
1981年 | 15篇 |
1980年 | 14篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 17篇 |
1976年 | 11篇 |
1975年 | 8篇 |
1970年 | 5篇 |
排序方式: 共有1826条查询结果,搜索用时 234 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
4.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
5.
6.
Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. 总被引:3,自引:2,他引:1 下载免费PDF全文
L IJlst J P Ruiter J M Hoovers M E Jakobs R J Wanders 《The Journal of clinical investigation》1996,98(4):1028-1033
Mitochondrial trifunctional protein (MTP) is a recently identified enzyme involved in mitochondrial beta-oxidation, harboring long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and long-chain 3-ketothiolase activity. A deficiency of this protein is associated with impaired oxidation of long-chain fatty acids which can lead to sudden infant death. Furthermore, it is clear that this inborn error of fatty acid oxidation is very frequent, second to medium chain acyl-CoA dehydrogenase deficiency. In most patients only the LCHAD activity of MTP is deficient with near normal activity of the two other enzyme activities of the complex. We recently described the occurrence of a frequent G1528C mutation in the cDNA coding for the a subunit of MTP. Using S. cerevisiae for expression of wild type and mutant protein we show that the G1528C mutation is directly responsible for the loss of LCHAD activity. Furthermore, we describe a newly developed method allowing identification of the G1528C mutation in genomic DNA. The finding of an 87% allele frequency of the G1528C mutation in 34 LCHAD deficient patients makes this a valuable test for prenatal diagnosis. Finally, we show that the gene encoding the alpha subunit of MTP is located on chromosome 2p24.1-23.3. 相似文献
7.
8.
9.
10.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献